Come up with a name for your new list and we'll add to it:
Incanthera raised a round of funding on January 20, 2012. Investors include
North West Fund for Biomedical.
Incanthera is an oncology company with a unique pipeline of technologies that target tumors. The lead cancer therapeutic opportunity is a new chemical entity called ICT2588, which has been designed to…